A high level of p‐p38/p‐ERK has been demonstrated in dormant tumors.[6, 28] Therefore, targeting QSOX2‐mTOR feedback loop, in combination with chemotherapy, shows promise in treating ESCC by reducing tumor stemness and promoting tumor dormancy. This evidence concerns the gene MTOR and neoplasm.